A multilabel non-ADNC classifier in an autopsy-confirmed cohort using demographic, genetic, clinical, MRI, and ADNC variables (Aβ and tau) showed accuracies of 84% for TDP-43, 81% for DLB, and 81% to 93% for CAA. This evidence concerns the gene MAPT and Lewy body dementia.